Yes, biotech stocks can beat the market.

Solt DB is a biotech equities research firm. Members have access to research notes, a real-time margin of safety dashboard, and our real-money portfolio.

Solt DB is a public benefit company.

No
ads, sponsors, or cheerleading
100%
transparent investments (members only)
Free
high-quality content

We teach scientists about investing.

Subscriptions to biotech stock research keep our website 100% ad, sponsor, and clickbait free. We nerd out with free public content, too.